Aug 27, 2026 07:30AM
Aug 27, 2026 07:30AM
Aug 6, 2026 04:01PM
Jun 9, 2026 07:30AM
Jun 9, 2026 07:30AM
May 7, 2026 04:01PM
Apr 23, 2026 07:30AM Corvus Pharmaceuticals adds former Genentech executive to board
Apr 23, 2026 07:30AM
Mar 12, 2026 04:01PM
Dec 8, 2025 10:30AM
Dec 8, 2025 10:30AM
Nov 4, 2025 04:01PM
Aug 7, 2025 04:01PM
Jun 4, 2025 07:01AM Corvus Pharma (CRVS) Announces Full Data from Cohort 3 of Placebo-Controlled Phase 1 Clinical Trial of Soquelitinib for Atopic Dermatitis
Jun 4, 2025 07:00AM
May 8, 2025 04:14PM
May 8, 2025 04:02PM
May 8, 2025 04:01PM
Mar 25, 2025 04:01PM
Mar 20, 2025 08:03AM
Mar 20, 2025 08:00AM Corvus Pharmaceuticals Announces Presentation of Additional Data from the Phase 1/1b Clinical Trial of Soquelitinib for Patients with T Cell Lymphoma
Jan 13, 2025 07:30AM
Jan 13, 2025 07:30AM
Nov 12, 2024 04:01PM
Sep 10, 2024 08:31AM
Sep 10, 2024 08:30AM
Aug 6, 2024 04:01PM
Aug 1, 2024 08:30AM Corvus Pharma (CRVS) Granted FDA Fast Track Designation for Soquelitinib
Aug 1, 2024 08:30AM
May 6, 2024 04:01PM
Mar 19, 2024 04:02PM
Feb 8, 2024 04:06PM
Feb 8, 2024 04:05PM
Nov 7, 2023 04:01PM
Nov 2, 2023 04:21AM Corvus Pharma (CRVS) Reports Publication of Preclinical Data Demonstrating Potential of ITK Inhibition with Soquelitinib
Nov 1, 2023 07:31PM
Sep 6, 2023 04:05PM
Aug 8, 2023 04:01PM
Jul 6, 2023 01:02PM
Jul 6, 2023 12:59PM
Jun 15, 2023 07:03AM
Jun 15, 2023 07:00AM Corvus Pharmaceuticals Presents New CPI-818 Interim Data at the International Conference on Malignant Lymphoma
May 17, 2023 09:00AM
May 8, 2023 04:01PM
Apr 17, 2023 09:01AM
Apr 17, 2023 09:00AM
Mar 28, 2023 04:02PM
Sep 26, 2022 05:44PM
Sep 17, 2021 09:28AM Pre-Open Stock Movers 09/17: (CRVS) (ABCL) (BGNE) Higher; (PTGX) (GRTS) (X) Lower (more...)
Jul 16, 2021 09:30AM

329,910 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All